Advertisement

Topics

New patent expiration for Teva Pharms drug SYNRIBO

00:06 EDT 16 Mar 2019 | BiotechBlog

Annual Drug Patent Expirations for SYNRIBO Synribo is a drug marketed by Teva Pharms Intl and is included in one NDA. It is available from one supplier. There are two…
The post New patent expiration for Teva Pharms drug SYNRIBO appeared first on DrugPa...

The post New patent expiration for Teva Pharms drug SYNRIBO appeared first on Biotechblog.

Original Article: New patent expiration for Teva Pharms drug SYNRIBO

NEXT ARTICLE

More From BioPortfolio on "New patent expiration for Teva Pharms drug SYNRIBO"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...